Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade

Clinical Cancer Research

Volumn 3, Issue 12 I, 1997, Pages 2269-2274

  Guo, Yanping ^a   Sklar, Geoffrey N ^a   Borkowski, Andrew ^a   Kyprianou, Natasha ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27;

ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL PROLIFERATION; CORRELATION FUNCTION; DIAGNOSTIC VALUE; GENE DELETION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROTEIN EXPRESSION;

ADENOCARCINOMA; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MITOTIC INDEX; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEINS;

EID: 0031409280     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Wingo, P. A., Tong, T. N., and Bolden, S. Cancer statistics. CA Cancer J. Clin., 45: 8-30, 1995.
2. Thompson, T. C. A review: Growth factors and oncogenes in prostate cancer. Cancer Cells, 2: 345-354, 1990.
3. Berges, R. R., Vucanovic, J., Epstein, J. I., CarMichel, M., Cisek, L., Johnson, D. E., Veltri, R. W., Walsh, P. C., and Isaacs, J. T. Implication of cell kinetic changes during the progression of human prostatic cancer. Clin. Cancer Res., 1: 473-480, 1995.
4. Tu, H., Jacobs, S. C., Borkowski, A., and Kyprianou, N. Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-β and bcl-2 expression. Int. J. Cancer, 69: 357-363, 1996.
5. Massague, J., Attisano, L., and Wrana, J. L. The TGF-β family and its composite receptors. Trends Cell Biol., 4: 172-178, 1994.
6. Martikainen, P., Kyprianou, N., and Isaacs, J. T. Effect of transforming growth factor-β on proliferation and death of rat prostatic cells. Endocrinology, 127: 2963-2968, 1990.
7. Hsing, A. Y., Kadomatsu, K., Bonham, M. J., and Danielpour, D. Regulation of apoptosis induced by transforming growth factor β1 in nontumorigenic and tumorigenic rat prostatic epithelial cell lines. Cancer Res., 56: 5146-5149, 1996.
8. Wrana, J., Attisano, L., Wieser, R., Ventura, F., and Massague, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370: 341-347, 1993.
9. 1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. USA, 90: 10315-10319, 1993.
10. 1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science (Washington DC), 260: 536-539, 1993.
11. Reynisdottir, I., Polyak, K., Iavarone, A., and Massague, J. Kip/Cip and Ink4 inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9: 1831-1845, 1995.
12. Ewen, M. E., Sluss, H. K., Whitehouse, L. L., and Livingston, D. M. TGF-β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell, 74: 1009-1020, 1993.
13. Polyak, K., Lee, M-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Temst, P., and Massague, J. Cloning of p27, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.
14. Kip1, a cyclin-cdk inhibitor links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
15. Williams, R. H., Stapleton, A. M. F., Yang, G., Truong, L. D., Rogers, E., Timme, T. L., Wheeler, T. M., Scardino, P. T., and Thompson, T. C. Reduced levels of transforming growth factor-β receptor type II in human prostate cancer: an immunohistochemical study. Clin. Cancer Res., 2: 635-640, 1996.
16. Kim, I. Y., Ahn, H-J., Zelner, D. J., Shaw, J. W., Lang, S., Kato, M., Oefelein, M. G., Miyazono, K., Nemeth, J. A., Kozlowski, J. M., and Lee, C. Loss of expression of transforming growth factor-β type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin. Cancer Res., 2: 1255-1261, 1996.
17. Guo, Y. P., Jacobs, S. C., and Kyprianou, N. Downregulation of protein and mRNA expression for TGF-β receptors type I and type II in human prostate cancer. Int. J. Cancer, 71: 1-9, 1997.
18. Gleason, D. F. Histologic grading and clinical staging of prostatic carcinoma. In: M. Tannenbaum and D. Febiber (eds.), Urologic Pathology: The Prostate, pp. 171-197. Philadelphia: Lea and Febiger, 1977.
19. SAS Institute, Inc. SAS/STAT User's Guide, Version 6, Vol. 2, GLM-VARCOMP, Ed. 4. Cary, NC: SAS Institute, Inc., 1989.
20. Peter, M., and Herskowitz, I. Joining the complex: cyclin dependent kinase inhibitory proteins and the cell cycle. Cell, 79: 181-184, 1994.
21. Kip1. Cell, 85: 721-732, 1996.
22. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell, 85: 707-720, 1996.
23. Kawamata, N., Morosetti, R., Miller, C. W., Park, D., Spirin, K. S., Nakamaki, T., Takeuchi, S., Hatta, Y., Simpson, J., Wilczynski, S., Lee, Y. Y., Bartman, C. R., and Koeffler, H. P. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res., 55: 2266-2269, 1995.
24. Kip1 accumulation during the cell cycle. Science (Washington DC), 271: 1861-1864, 1996.
25. Kip1 and induces G, arrest in prostatic cancer cell line DU-145. Cancer Res., 56: 3666-3669, 1996.
26. Truong, L. D., Kadmon, D., McCune, B., Flanders, K. C., Scardino, P. T., and Thompson, T. C. Association of TGF-β with prostate cancer: an immunohistochemical study. Hum. Pathol., 24: 4-9, 1993.
27. Mashal, R. D., Lester, S., Corless, C., Richie, J. P., Chandra, R., Propert, K. J., and Dutta, A. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res., 56: 4159-4163, 1996.
28. Keyomarsi, K., O'Leary, N., Molnar, G., Less, E., Fingert, H. J., and Pardee, A. B. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54: 380-385, 1994.
29. Sadi, M. V., and Barrack, E. R. Determination of growth fraction in advanced prostate cancer by Ki-67 immunostaining and its relationship to the time of tumor progression after hormonal therapy. Cancer (Phila.), 67: 3065-3071, 1991.
30. McLoughlin. J., Foster, C. S., Price, P., Williams, G., and Abel, P. D. Evaluation of Ki-67 monoclonal antibody as prognostic indicator for prostatic carcinoma. Br. J. Urol., 72: 92-97, 1993.
31. Kamb, A., Gruis, N. A., Weaver-Feldfaus, J., Liu, Q., Harsham, K., Tavtigian, S. V., Stocken, E., Day, R. S., III, Johnson, B. E., and Scholinck, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.